New patent expiration for Abbvie drug LATISSE
Annual Drug Patent Expirations for LATISSE Latisse is a drug marketed by Abbvie and is included in one NDA. It […]
Annual Drug Patent Expirations for LATISSE Latisse is a drug marketed by Abbvie and is included in one NDA. It […]
Annual Drug Patent Expirations for CHILDREN%27S+ADVIL+ALLERGY+SINUS For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
New patent expiration for Haleon Us drug CHILDREN’S ADVIL ALLERGY SINUS Read Post »
Annual Drug Patent Expirations for ORENITRAM Orenitram is a drug marketed by United Therap and is included in one NDA.
New patent expiration for United Therap drug ORENITRAM Read Post »
Annual Drug Patent Expirations for REMODULIN Remodulin is a drug marketed by United Therap and is included in two NDAs.
New patent expiration for United Therap drug REMODULIN Read Post »
Annual Drug Patent Expirations for NAROPIN Naropin is a drug marketed by Fresenius Kabi Usa and is included in one
New patent expiration for Fresenius Kabi drug NAROPIN Read Post »
Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two
New patent expiration for Merck Sharp drug PREVYMIS Read Post »
Annual Drug Patent Expirations for VIZAMYL Vizamyl is a drug marketed by Ge Healthcare and is included in one NDA.
New patent expiration for Ge Healthcare drug VIZAMYL Read Post »
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA.
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
Get fresh news and insights, drug patent expirations & more…